[1] CABO J, GALLAGHER K C, BAREGAMIAN N. Challenges and controversies in the surgical management of uremic hyperparathyroidism: A systematic review[J]. Am J Surg, 2018, 216(4): 713-722. [2] IMANISHI Y. Oral calcimimetics on secondary hyperparathyroidism of uremia[J]. Clin Calcium, 2017, 27(4): 561-566. [3] IWASAKI Y, KAZAMA J J, FUKAGAWA M. molecular abnormalities underlying bone fragility in chronic kidney disease[J]. Biomed Res Int, 2017, 2017: 3485785. [4] JAIRATH N N, PEDEN-MCALPINE C J, SULLIVAN M C, et al. Theory and Theorizing in Nursing Science: Commentary from the Nursing Research Special Issue Editorial Team[J]. Nurs Res, 2018, 67(2): 188-195. [5] STARKWEATHER A, JACELON C S, BAKKEN S, et al. The Use of Technology to Support Precision Health in Nursing Science[J]. J Nurs Scholarsh, 2019, 51(6): 614-623. [6] ZHU L, XIONG F, CUI T.Evaluation of the different surgical parathyroidectomies on secondary hyperparathyroidism in uremia patients[J]. Minerva Endocrinol, 2018, 43(3): 391-393. [7] CABO J, GALLAGHER K C, BAREGAMIAN N. Challenges and controversies in the surgical management of uremic hyperparathyroidism: A systematic review[J]. Am J Surg, 2018, 216(4): 713-722. [8] KAWATA T, IMANISHI Y, KOBAYASHI K, et al.Direct in vitro evidence of extracellular Ca2+-induced amino-terminal truncation of human parathyroid hormone (1-84) by human parathyroid cells[J]. J Clin Endocrinol Metab, 2005, 90(10): 5774-5778. [9] 邓慧, 隆卫娟. 以控制论为核心理念的护理对血液透析尿毒症患者消极情感及不良事件的影响[J]. 河北医药, 2017, 39(1): 158-160. [10] HEYNE N.Expanded hemodialysis therapy: prescription and delivery[J]. Contrib Nephrol, 2017, 191: 153-157. [11] ZAZZERONI L, PASQUINELLI G, NANNI E, et al.Comparison of quality of life in patients undergoing hemodialysis and peritoneal dialysis: a systematic review and meta-analysis[J]. Kidney Blood Press Res, 2017, 42(4): 717-727. [12] 王晶, 陈帼英. 尿毒症腹膜透析患者并发腹壁疝的术后护理 [J]. 护士进修杂志, 2018, 9: 811-812. [13] 林华志, 赵李晋, 谢巧玲, 等. 护理对血液透析患者动静脉内瘘并发症发生率的影响[J]. 浙江医学, 2016, 38(21): 1777-1779. |